01 1Alivus Life Sciences
01 1ALOGLIPTIN BENZOATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2016-04-19
Pay. Date : 2016-03-17
DMF Number : 30057
Submission : 2016-02-08
Status : Active
Type : II
20
Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ALOGLIPTIN BENZOATE, with a corresponding US DMF Number 30057.
Remarkably, this DMF maintains an Active status since its submission on February 08, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 19, 2016, and payment made on March 17, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
